Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)

15.67
Delayed Data
As of Mar 27
 +0.23 / +1.49%
Today’s Change
9.01
Today|||52-Week Range
17.11
+2.28%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$2.2B

Company Description

Ironwood Pharmaceuticals, Inc. is an entrepreneurial pharmaceutical company. It discovers, develops and intends to commercialize differentiated medicines that improve patient's lives. Its product candidate is linaclotide, a guanylate cyclase type-C agonist being developed for the treatment of patients with irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook, Jr. and Gina Bornino Miller on January 5, 1998 and is headquartered in Cambridge, MA.

Contact Information

Ironwood Pharmaceuticals, Inc.
301 Binney Street
Cambridge Massachusetts 02142
P:(617) 621-7722
Investor Relations:
(617) 374-5082

Employees

Shareholders

Individual stakeholders8.56%
Mutual fund holders66.21%
Other institutional41.44%

Top Executives

Peter M. HechtChief Executive Officer & Director
Thomas GraneyChief Financial Officer & SVP-Corporate Strategy
Mark G. CurrieChief Scientific Officer & Senior Vice President
Jeffrey M. JohnstonChief Medical Officer & VP-Clinical Development
Michael L. HallSenior Vice President-Clinical Development

To view my watchlist

Not a member yet?

Sign up now for a free account